Works by McQuade, Robert D.

Results: 23

Correction to: An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 6, p. 939, doi. 10.1007/s00228-020-03071-z

By:

Wong, Dean F.;
Raoufinia, Arash;
Bricmont, Patricia;
Brašić, James R.;
McQuade, Robert D.;
Forbes, Robert A.;
Kikuchi, Tetsuro;
Kuwabara, Hiroto

Publication type:

Article

An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 5, p. 717, doi. 10.1007/s00228-020-03021-9

By:

Wong, Dean F.;
Raoufinia, Arash;
Bricmont, Patricia;
Brašić, James R.;
McQuade, Robert D.;
Forbes, Robert A.;
Kikuchi, Tetsuro;
Kuwabara, Hiroto

Publication type:

Article

Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.

Published in:

International Journal of Psychiatry in Clinical Practice, 2012, v. 16, n. 2, p. 121, doi. 10.3109/13651501.2011.632680

By:

Thase, Michael E.;
Bowden, Charles L.;
Nashat, Michael;
Eudicone, James M.;
Marcus, Ronald;
Mcquade, Robert D.;
Carlson, Berit X.

Publication type:

Article

Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study.

Published in:

Bipolar Disorders, 2013, v. 15, n. 2, p. 138, doi. 10.1111/bdi.12042

By:

Findling, Robert L;
Correll, Christoph U;
Nyilas, Margaretta;
Forbes, Robert A;
McQuade, Robert D;
Jin, Na;
Ivanova, Svetlana;
Mankoski, Raymond;
Carson, William H;
Carlson, Gabrielle A

Publication type:

Article

Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392).

Published in:

Bipolar Disorders, 2012, v. 14, n. 1, p. 41, doi. 10.1111/j.1399-5618.2011.00974.x

By:

Carlson, Berit X;
Ketter, Terence A;
Sun, Wei;
Timko, Karen;
McQuade, Robert D;
Sanchez, Raymond;
Vester‐Blokland, Estelle;
Marcus, Ronald

Publication type:

Article

In vivo binding properties of non-sedating antihistamines to CNS histamine receptors.

Published in:

Drug Development Research, 1990, v. 20, n. 3, p. 301, doi. 10.1002/ddr.430200305

By:

McQuade, Robert D.;
Richlan, Kimberly;
Duffy, Ruth A.;
Chipkin, Richard E.;
Barnett, Allen

Publication type:

Article

Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration.

Published in:

International Journal of Neuropsychopharmacology, 2017, v. 20, n. 4, p. 295, doi. 10.1093/ijnp/pyw116

By:

Raoufinia, Arash;
Peters-Strickland, Timothy;
Nylander, Anna-Greta;
Baker, Ross A.;
Eramo, Anna;
Na Jin;
Bricmont, Patricia;
Repella, Jennifer;
McQuade, Robert D.;
Hertel, Peter;
Larsen, Frank

Publication type:

Article

Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study.

Published in:

International Journal of Neuropsychopharmacology, 2017, v. 20, n. 1, p. 11, doi. 10.1093/ijnp/pyw076

By:

Fleischhacker, W. Wolfgang;
Hobart, Mary;
Ouyang, John;
Forbes, Andy;
Pfister, Stephanie;
McQuade, Robert D.;
Carson, William H.;
Sanchez, Raymond;
Nyilas, Margareta;
Weiller, Emmanuelle

Publication type:

Article

Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial.

Published in:

International Journal of Neuropsychopharmacology, 2010, v. 13, n. 8, p. 1115, doi. 10.1017/S1461145710000490

By:

Fleischhacker, W. Wolfgang;
Heikkinen, Martti E.;
Olié, Jean-Pierre;
Landsberg, Wally;
Dewaele, Patricia;
McQuade, Robert D.;
Loze, Jean-Yves;
Hennicken, Delphine;
Kerselaers, Wendy

Publication type:

Article

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 325, doi. 10.1017/s1461145703003651

By:

Siegfried Kasper;
Mark N. Lerman;
Robert D. McQuade;
Anutosh Saha;
William H. Carson;
Mirza Ali;
Donald Archibald;
Gary Ingenito;
Ronald Marcus;
Teresa Pigott

Publication type:

Article

Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

Published in:

2009

By:

Berman RM;
Fava M;
Thase ME;
Trivedi MH;
Swanink R;
McQuade RD;
Carson WH;
Adson D;
Taylor L;
Hazel J;
Marcus RN;
Berman, Robert M;
Fava, Maurizio;
Thase, Michael E;
Trivedi, Madhukar H;
Swanink, René;
McQuade, Robert D;
Carson, William H;
Adson, David;
Taylor, Leslie

Publication type:

journal article

Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with InadequateResponse to Antidepressants.

Published in:

CNS Spectrums: The International Journal of Neuropsychiatric Medicine, 2009, v. 14, n. 4, p. 197, doi. 10.1017/S1092852900020216

By:

Berman, Robert M.;
Fava, Maurizio;
Thase, Michael E.;
Trivedi, Madhukar H.;
Swanink, René;
McQuade, Robert D.;
Carson, William H.;
Adson, David;
Taylor, Leslie;
Hazel, James;
Marcus, Ronald N.

Publication type:

Article

[3H]SCH 39166, A New D1-Selective Radioligand: In Vitro and In Vivo Binding Analyses.

Published in:

Journal of Neurochemistry, 1991, v. 57, n. 6, p. 2001, doi. 10.1111/j.1471-4159.1991.tb06415.x

By:

McQuade, Robert D.;
Duffy, Ruth A.;
Anderson, Cheryl C.;
Crosby, Gordon;
Coffin, Vicki L.;
Chipkin, Richard E.;
Barnett, Allen

Publication type:

Article

Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study.

Published in:

2018

By:

Hobart, Mary;
Skuban, Aleksandar;
Zhang, Peter;
Josiassen, Mette Krog;
Hefting, Nanco;
Augustine, Carole;
Brewer, Claudette;
Sanchez, Raymond;
McQuade, Robert D.

Publication type:

journal article

Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.

Published in:

Current Medical Research & Opinion, 2010, v. 26, n. 6, p. 1485, doi. 10.1185/03007991003779380

By:

Eduard Vieta;
Randall Owen;
Christine Baudelet;
Robert D. McQuade;
Raymond Sanchez;
Ronald N. Marcus

Publication type:

Article

Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 2, p. 134, doi. 10.1002/npr2.12180

By:

Kikuchi, Tetsuro;
Maeda, Kenji;
Suzuki, Mikio;
Hirose, Tsuyoshi;
Futamura, Takashi;
McQuade, Robert D.

Publication type:

Article

Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.

Published in:

Psychopharmacology, 2006, v. 189, n. 2, p. 259, doi. 10.1007/s00213-006-0564-3

By:

Chrzanowski, Wlodzimierz K.;
Marcus, Ronald N.;
Torbeyns, Anne;
Nyilas, Margaretta;
McQuade, Robert D.

Publication type:

Article

The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine.

Published in:

Psychopharmacology, 2006, v. 187, n. 3, p. 312, doi. 10.1007/s00213-006-0428-x

By:

Kern, Robert S.;
Green, Michael F.;
Cornblatt, Barbara A.;
Owen, J. Randall;
McQuade, Robert D.;
Carson, William H.;
Ali, Mirza;
Marcus, Ron

Publication type:

Article

Short-term physical compatibility of intramuscular aripiprazole with intramuscular lorazepam.

Published in:

American Journal of Health-System Pharmacy, 2008, v. 65, n. 21, p. 2007, doi. 10.2146/ajhp070067

By:

Kovalick, Lawrence J.;
Pikalov, Andrei A.;
Ni, Nina;
Naringrekar, Vijay H.;
McQuade, Robert D.

Publication type:

Article

Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care

Published in:

European Psychiatry, 2008, v. 23, n. 8, p. 561, doi. 10.1016/j.eurpsy.2008.01.1421

By:

Kolotkin, Ronette L.;
Corey-Lisle, Patricia K.;
Crosby, Ross D.;
Kan, Hong J.;
McQuade, Robert D.

Publication type:

Article

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study

Published in:

European Psychiatry, 2007, v. 22, n. 7, p. 433, doi. 10.1016/j.eurpsy.2007.03.002

By:

Kerwin, Robert;
Millet, Bruno;
Herman, Erik;
Banki, Csaba M.;
Lublin, Henrik;
Pans, Miranda;
Hanssens, Linda;
L'Italien, Gilbert;
McQuade, Robert D.;
Beuzen, Jean-Noël

Publication type:

Article

Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010).

Published in:

Psychopharmacology Bulletin, 2008, v. 41, n. 2, p. 12

By:

Masand, Prakash S.;
Eudicone, James;
Pikalov, Andrei;
McQuade, Robert D.;
Marcus, Ronald N.;
Vester-Blokland, Estelle;
Carlson, Berit X.

Publication type:

Article

CLINICAL OUTCOMES IN MEASUREMENT-BASED TREATMENT ( COMET): A TRIAL OF DEPRESSION MONITORING AND FEEDBACK TO PRIMARY CARE PHYSICIANS.

Published in:

Depression & Anxiety (1091-4269), 2012, v. 29, n. 10, p. 865, doi. 10.1002/da.21983

By:

Yeung, Albert S.;
Jing, Yonghua;
Brenneman, Susan K.;
Chang, Trina E.;
Baer, Lee;
Hebden, Tony;
Kalsekar, Iftekhar;
McQuade, Robert D.;
Kurlander, Jonathan;
Siebenaler, Jean;
Fava, Maurizio

Publication type:

Article

Works by McQuade, Robert D.

Correction to: An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants.

An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants.

Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.

Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study.

Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392).

In vivo binding properties of non-sedating antihistamines to CNS histamine receptors.

Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration.

Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study.

Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial.

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.

Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with InadequateResponse to Antidepressants.

[<sup>3</sup>H]SCH 39166, A New D<sub>1</sub>-Selective Radioligand: In Vitro and In Vivo Binding Analyses.

Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study.

Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.

Discovery research and development history of the dopamine D<sub>2</sub> receptor partial agonists, aripiprazole and brexpiprazole.

Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.

The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine.

Short-term physical compatibility of intramuscular aripiprazole with intramuscular lorazepam.

Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study

Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010).

CLINICAL OUTCOMES IN MEASUREMENT-BASED TREATMENT ( COMET): A TRIAL OF DEPRESSION MONITORING AND FEEDBACK TO PRIMARY CARE PHYSICIANS.